1. Market Research
  2. > Biological Therapy Industry

Gene Therapy Industry, July 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Blood Disease, Healthcare, Pharmaceutical, Tissue Engineering, Cell Therapy, Bioinformatic, Biopharmaceutical, Cancer, Cell Culture, Wound Care, Biobanking, Cardiac Management, Cardiology, Cystic Fibrosis, Dementia, Dermatological Condition, Eye Disease, Factor VIII, Graphene.


 
1-10 of 20 reports for Gene Therapy

Purchase Reports From Reputable Market Research Publishers

Gene Therapy Ophthalmology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2017

  • $ 2950
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s report, “Gene Therapy Ophthalmology Insight - Pipeline Assessment, Market Trend, Technology and Competitive Landscape, 2017” emphasizes on the currently under development Gene Therapy ...

The 2018-2023 World Outlook for Gene Therapy

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for gene therapy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ...

Global Gene Therapy Partnering Terms and Agreements 2010 to 2017

  • $ 2995
  • Industry report
  • April 2017
  • by Currentpartnering

Summary The Global Gene Therapy Partnering Terms and Agreements 2010-2017 report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered ...

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Biological Safety Testing Market Analysis By Product (Reagents & Kits, Instruments, Services), By Application (Stem Cell, Tissue & Tissue-Based Products, Gene Therapy, Blood & Blood-Based Products, Vaccines & Therapeutics), By Test, And Segment Forecasts

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The biological safety testing market is expected to reach USD 5.54 billion by 2024, according to a new report by Grand View Research, Inc. The biological safety testing market is primarily driven by exponential ...

Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Regenerative medicines are capable of restoring the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicines are used in a wide range of degenerative ...

Gene Therapy in Oncology Drug Pipeline Update

  • $ 2250
  • Industry report
  • August 2016
  • by Bioseeker

There are today 125 companies plus partners developing 103 gene therapy drugs in 262 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period

  • $ 4995
  • Industry report
  • August 2016
  • by GBI Research

Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period Summary Ophthalmology is a therapy area that deals with the diagnosis, ...

Trends in Gene Therapy

  • $ 5000
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products have received regulatory approval ...

Hemophilia Market Analysis By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement Therapy, Immune Tolerance Induction [ITI]Therapy, Gene Therapy), And Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • July 2016
  • by Grand View Research

Global hemophilia market is expected to reach USD 15.2 billion by 2024, according to a new report by Grand View Research, Inc. Increasing need for diagnosis of the target population in order to initiate ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.